Turing's Shkreli Tussles With Express Scripts About 'Ugly, Dirty Truth' Of Drug Pricing
This article was originally published in Scrip
Executive Summary
Turing Pharmaceuticals AG CEO Martin Shkreli shrugged off the angry criticism he has received for sharply hiking the price of the anti-parasitic Daraprim (pyrimethamine), saying he had a duty to shareholders to maximize their profit.